However, as seen in other tissues/diseases, expression of NKG2D ligands in hepatitis-associated conditions is heterogeneous, and there is still conflicting evidence as to the beneficial versus deleterious role of NKG2D in hepatitis. Here, KLRK1 is linked to Hepatitis.